BeiGene eyes $933m in latest HK biotech offering

John Loh

July 30, 2018 06:30 am

medical waste — Disposal of hazardous waste in the hospital | sudok1 - Fotolia

BeiGene is set to become the first issuer to sell shares under new rules in Hong Kong, after the exchange moved to encourage secondary listings by overseas-traded companies.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC Securities Credit Suisse Equity IPOs Equity China Hong Kong SAR Asia Follow-ons and Rights Issues Asia Greater China Morgan Stanley Northeast Asia Asia Pacific Follow-ons and Rights issues Emerging Markets Goldman Sachs

JL

John Loh